CA2176960C - Novel carbamate compounds and processes for preparing the same - Google Patents
Novel carbamate compounds and processes for preparing the same Download PDFInfo
- Publication number
- CA2176960C CA2176960C CA002176960A CA2176960A CA2176960C CA 2176960 C CA2176960 C CA 2176960C CA 002176960 A CA002176960 A CA 002176960A CA 2176960 A CA2176960 A CA 2176960A CA 2176960 C CA2176960 C CA 2176960C
- Authority
- CA
- Canada
- Prior art keywords
- acetoxy
- carbamate
- propanol
- accordance
- represented
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
- C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C271/12—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
- C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C271/16—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by singly-bound oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/10—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and singly-bound oxygen atoms bound to the same carbon skeleton
- C07C323/18—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and singly-bound oxygen atoms bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton
- C07C323/19—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and singly-bound oxygen atoms bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton with singly-bound oxygen atoms bound to acyclic carbon atoms of the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
- C07D213/30—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/61—Halogen atoms or nitro radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/69—Two or more oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/70—Sulfur atoms
Abstract
(S)-2-aryl-1,3-propanediol and its intermediate, (5)-3-acetoxy-2-aryl-propan ol carbamate, represented by formulae (I) and (II), respectively, have pharmaceutically useful activity against centra l nervous system disorders including nervous myalgia, ep ilepsy and cerebral apoplexy, wherein, R is (a), (b), (c), (d), (e), (f), (g), (h), (i) or (j), wherein X is an oxygen atom or 3 sulfur ato m; and Y represents a halogen element, trifluoromethyl, or a lower alkyl group contai ning one to three carbon atoms.
Description
R'O 96109283 2 ~ 7 6 9 6 0 PCTIKR95I00124 NOVEL CARBAMATE COMPOUNDS AND PROCESSES FOR PREPARING
THE SAME
BACRGROUND OF THE INVENTION
Field of the invention The present invention relates, in general, to novel enantiomeric carbamate compounds pharmaceutically useful for central nervous disorders and, more particularly, to (S)-2-aryl-1,3-propanediol monocarbamate derived from (R)-3-acetoxy-2-arylpropanol carbamate and to (S)-3-acetoxy-2-aryipropanol carbamate, its intermediate. Also, the present invention is concerned with processes for preparing the novel carbamate compounds.
Description of the Prior Art Carbamates have been effectively used for controlling central nervous system (hereinafter referred to as "CNS") disorders, especially, as an antiepiletic and a centrally acting muscle relaxant. For example, 2-methyl-2-propyl 1,3-propanediol dicarbamate was reported in J. Am. Chem.
Soc., 73, 5779 (1951), and the pharmaceutical activity thereof was ascertained in J. Pharmacol. Exp. Ther., 104, 229 (1952).
U.S. Pat. No. 3,256,728 discloses that the compounds, represented by the following general formula A, are pharmaceutically useful therapeutics for CNS disorders.
WO 96/09283 ~ ~ 7 6 9 6 0 PCT/KR95/00124 R
Rz [A] ' ~ R3 Z
wherein, R1 is a carbamate or methylene carbamate; RZ is an alkyl group containing one or two carbon atoms, a hydroxy alkyl group containing one or two carbon atoms, hydroxy or hydrogen; R3 is hydrogen or an alkyl group containing one or two carbon atoms; and Z represents a halogen such as fluorine, chlorine, bromine or iodine, a methylmethoxy group, a phenyl group, a vitro group or an amine group.
Besides, other carbamate compounds which are very useful therapeutic medicines against CNS disorders, in particular, as antiepiletic and centrally acting muscle relaxant, ate disclosed, including 2-phenyl-1,3-propanediol dicarbamate in U.S. Pat. No. 2,884,444 and isopropyl meprobamate in U.S. Pat. No. 2,937,119. At present, various researches for such carbamate compounds are being actively continued in the art.
SUMMARY OF THE INVENTION
Based on intensive and thorough study and research by the present inventors, it was found that the carbamate compounds represented by the following structural formulas I and II are useful for the treatment and prevention of W O 96109283 2 l 7 6 9 6 0 PCTlKR95100124 CNS diseases including nervous myalgia, epilepsy and ' cerebral apoplexy:
R ~ CH20H
[I]
CHZOCONHZ
[II]
CHZOCONHZ
wherein, R is O O Y O Y O XY O XY
' ' Y ' ' YX ' Y Y XY XY
r C~ or YX--~
N , N , , , N
wherein X is an oxygen atom or a sulfur atom; and Y
repre°- is a halogen element, trifluoromethyl, or a lower alkyl ~~oup containing one to three carbon atoms.
In addition, taking advantage of the far superior activity of single enantiomeric isomer to racemic mixture in biological systems, the present inventors developed the enantiomers of Formulas I and II, which had never been WO 96109283 217 6 9 6 0 PCT~~00124 found, and applied them as pharmaceutically active ingredients against CNS diseases.
The carbamate compounds of Formulas I and II are chiral molecules with a chiral center of carbon at 2 propyl and may have either an (S) or (R)-configuration.
Accordingly, it is an-object of the present invention to provide novel (S)-enantiomeric compounds represented by Formulas I and II-, which have pharmaceutically useful activity against central nervous system diseases.
It is another object of the present invention to provide a method for preparing the compounds of Formulas I and II at high yield and high purity within a short time.
DETAILED DESCRIPTION OF THE INVENTION
The compound of Formula II can be prepared by treating (R)-3-acetoxy-2-aryl-propanol, represented by the following formula III:
[III]
CHZOH
wherein, R is as defined above, with phosgene in a mixture of aromatic hydrocarbon and halogenohydrocarbon in the presence of amine base, and followed by anhydrous ammonia.
Available aromatic hydrocarbons include benzene, WO 96109283 2 ~ 7 6 9 6 0 PCT/KR95/0012~1 toluene and xylene and a halogenohydrocarbon is selected ' from the group consisting of chloroform, dicholomethane, 1,2-dichloroethane and trichloroethane. The preferred solvent is a mixture of toluene and dichloromethane.
THE SAME
BACRGROUND OF THE INVENTION
Field of the invention The present invention relates, in general, to novel enantiomeric carbamate compounds pharmaceutically useful for central nervous disorders and, more particularly, to (S)-2-aryl-1,3-propanediol monocarbamate derived from (R)-3-acetoxy-2-arylpropanol carbamate and to (S)-3-acetoxy-2-aryipropanol carbamate, its intermediate. Also, the present invention is concerned with processes for preparing the novel carbamate compounds.
Description of the Prior Art Carbamates have been effectively used for controlling central nervous system (hereinafter referred to as "CNS") disorders, especially, as an antiepiletic and a centrally acting muscle relaxant. For example, 2-methyl-2-propyl 1,3-propanediol dicarbamate was reported in J. Am. Chem.
Soc., 73, 5779 (1951), and the pharmaceutical activity thereof was ascertained in J. Pharmacol. Exp. Ther., 104, 229 (1952).
U.S. Pat. No. 3,256,728 discloses that the compounds, represented by the following general formula A, are pharmaceutically useful therapeutics for CNS disorders.
WO 96/09283 ~ ~ 7 6 9 6 0 PCT/KR95/00124 R
Rz [A] ' ~ R3 Z
wherein, R1 is a carbamate or methylene carbamate; RZ is an alkyl group containing one or two carbon atoms, a hydroxy alkyl group containing one or two carbon atoms, hydroxy or hydrogen; R3 is hydrogen or an alkyl group containing one or two carbon atoms; and Z represents a halogen such as fluorine, chlorine, bromine or iodine, a methylmethoxy group, a phenyl group, a vitro group or an amine group.
Besides, other carbamate compounds which are very useful therapeutic medicines against CNS disorders, in particular, as antiepiletic and centrally acting muscle relaxant, ate disclosed, including 2-phenyl-1,3-propanediol dicarbamate in U.S. Pat. No. 2,884,444 and isopropyl meprobamate in U.S. Pat. No. 2,937,119. At present, various researches for such carbamate compounds are being actively continued in the art.
SUMMARY OF THE INVENTION
Based on intensive and thorough study and research by the present inventors, it was found that the carbamate compounds represented by the following structural formulas I and II are useful for the treatment and prevention of W O 96109283 2 l 7 6 9 6 0 PCTlKR95100124 CNS diseases including nervous myalgia, epilepsy and ' cerebral apoplexy:
R ~ CH20H
[I]
CHZOCONHZ
[II]
CHZOCONHZ
wherein, R is O O Y O Y O XY O XY
' ' Y ' ' YX ' Y Y XY XY
r C~ or YX--~
N , N , , , N
wherein X is an oxygen atom or a sulfur atom; and Y
repre°- is a halogen element, trifluoromethyl, or a lower alkyl ~~oup containing one to three carbon atoms.
In addition, taking advantage of the far superior activity of single enantiomeric isomer to racemic mixture in biological systems, the present inventors developed the enantiomers of Formulas I and II, which had never been WO 96109283 217 6 9 6 0 PCT~~00124 found, and applied them as pharmaceutically active ingredients against CNS diseases.
The carbamate compounds of Formulas I and II are chiral molecules with a chiral center of carbon at 2 propyl and may have either an (S) or (R)-configuration.
Accordingly, it is an-object of the present invention to provide novel (S)-enantiomeric compounds represented by Formulas I and II-, which have pharmaceutically useful activity against central nervous system diseases.
It is another object of the present invention to provide a method for preparing the compounds of Formulas I and II at high yield and high purity within a short time.
DETAILED DESCRIPTION OF THE INVENTION
The compound of Formula II can be prepared by treating (R)-3-acetoxy-2-aryl-propanol, represented by the following formula III:
[III]
CHZOH
wherein, R is as defined above, with phosgene in a mixture of aromatic hydrocarbon and halogenohydrocarbon in the presence of amine base, and followed by anhydrous ammonia.
Available aromatic hydrocarbons include benzene, WO 96109283 2 ~ 7 6 9 6 0 PCT/KR95/0012~1 toluene and xylene and a halogenohydrocarbon is selected ' from the group consisting of chloroform, dicholomethane, 1,2-dichloroethane and trichloroethane. The preferred solvent is a mixture of toluene and dichloromethane.
5 As the amine base, antipyrine, diisopropylethylamine, diethylamine, triethylamine or pyridine is available, with a preference to such a sterically hindered base as triethylamine, diisopropylethylamine or antipyrine.
Temperature is maintained at -30 to 0 'C upon reaction with phosgene while the reaction with anhydrous ammonia is carried out at a temperature of -70 to 0 'C.
For use, anhydrous ammonia is condensed to a liquid.
It is added at an excess of 10 to 100 equivalents and preferably at an excess of 25 to 50 equivalents.
In accordance with the present invention, the compound of Formula I can be converted from (S)-3-acetoxy-2-aryl-propanol carbamate, represented by Formula II, through the catalytic reaction of hydrolase in a buffer solution. High yield and optical purity can be accomplished within a short time by the enzymatic hydrolysis of (S)-3-acetoxy-2-aryl-propanol carbamate into (S)-2-aryl-1,3-propanediol monocarbamate.
Generally, enzymes show a far higher catalytic activity than chemical catalysts while giving less by-products.--In addition, since the enzymatic conversion of (S)-3-acetoxy-2-arylpropanol carbamate into (S)-2-aryl-1,3-propanediol monocarbamate is carried out at a low WO 96109283 t ' y ~ 2 l 7 6 9 6 0 PCT/KR95100124 temperature in a neutral aqueous solution, for example, phosphate buffer solution, the side-reactions attributable ' to the enzyme can be eliminated. Following the hydrolysis, the enzyme used can be almost completely removed only by filtration without lowering the product yield. Accordingly, the present invention is very advantageous in time and cost.
In more detail, the (S)-3-acetoxy-2-arylpropanol carbamate of Formula II is dissolved in a phosphate buffer solution and then, vigorously stirred at a temperature of 0 to 35 'C and with ordinary pressure in the presence of hydrolase. Preference is given to a temperature of 10 to 25 'C. Care must be taken to control the reaction temperature. A reaction temperature of higher than 35 'C
makes the hydrolysis proceed faster but causes the enzyme to be lowered in selectivity, deleteriously affecting the optical purity of the product.
The phosphate buffer solution has a pH ranging from 6 to 9 with a preference of 7. For example, if the phosphate buffer solution has a pH of higher or lower than 7, the optical purity of the product becomes poor. In order for the selectivity of the enzyme not to be lowered, the phosphate buffer solution is preferably diluted into 0.01 to 0.1 mole solution.
With regard to the hydrolase used for the conversion, various sources are available. Representative examples include lipase extracted from pig's pancreas (PPL), WO 96109283 217 6 9 6 0 PCT/KR9510012.1 Candida lipase (CCL), Aspagillus lipase (ANL), Pseudomona5 ' lipase (PSL) and an esterase from pig's liver (PLE), with a preference for PLE.
Usually at 4 to 5 hours after adding the enzyme, the conversion reaction of (S)-3-acetoxy-2-aryl-propanol carbamate into (S)-2-aryl-1,3-propanediol monocarbamate is terminated. Thin layer chromatography or high performance liquid chromatography may be used to determine the termination point of the conversion reaction.
From the resultant reaction mixture, the enzyme may be filtered off simply and then, the solvent is removed by using a rotary evaporator. Purification by column chromatography gives (S)-2-aryl-1,3-propanediol monocarbamate of Formula I, a novel compound.
Likewise, (R)-3-acetoxy-2-aryl-propanol of Formula III can be prepared by use of an enzyme. For this, PPL, CCL or PSL is immobilized to cellite. Preference is given to PPL and PSL_ 2-aryl-1,3-propanediol is dissolved in anhydrous alkyl acetate, such as methyl acetate, ethyl acetate, propyl acetate and vinyl acetate, or anhydrous alkenyl acetate and incubated at a temperature of -10 to 35 'C. Following this, the reactant is added with the immobilized catalyst system in the absence of solvent while vigorously stirring. At this moment, the reaction is carried out preferably at a temperature of 0 to 35 'C
under ordinary pressure. Particularly, care must be taken to control the temperature below 35 'C because higher W O 96/09283 , ; ~ ; ' _ 2 ~ 7 6 9 6 0 PCTIKR95100124 temperature makes the reaction proceed too fast, resulting in degradation of optical purity.
High performance liquid chromatography can also be used about 3 hours-after the reaction, to determine the termination of the reaction. Five hours after the reaction is usual-ly enough to obtain the compound of Formula III with a yield of 85 % or larger and an optical purity of 99 % or more.
To identify (S)-2-aryl-1,3-propanediol monocarbamate as a pharmaceutically useful material, anticonvulsant activity assay of the novel compound of the present invention was executed through standard Maximal Electro Shock (MES) test. To the end, 0.5 g (S)-2-phenyl-1,3 propanediol monocarbamate was suspended in 100 ml buffer solution at pH 7.4. The prepared suspension was administered into ten male CD-2 mice weighing about 20 to g at a dose of 300 mg/kg. Oral administration through a syringe is preferred. At one hour after administration, the middle of the forehead of the mice was electrically 20 shocked at 50 mA for 0.2 second by use of corneal electrode. Of the ten mice administered with the compound of the present invention, nine were not convulsed and acted as usual_ Only one was convulsed. to death.
A better understanding of the present invention may 25 be obtained in light of following examples which are set forth to illustrate, and are not to be construed to limit, the present invention.
WO 96/09283 ~ 21 l 6 9 6 0 PCTJKR95/00124 EXAMPLE I
(S)-3-Acetoxy-Z-(2-pyridyl) propanol carbamate 500 ml flask equipped with a thermometer was well dried and purged by flowing nitrogen gas into the inside thereof for 30 min. After the moisture and air present within the flask was replaced by nitrogen gas, 24.5 mI of 0.6 M phosgene solution was placed in the purged flask, followed by the addition of 150 mI of toluene. The flask was maintained at -30 'C in a bath containing dry ice and acetone.
Separately, 2.0 g of (R}-3-acetoxy-2-(2-pyridyl)propanol and 4.7 g of antipyrine were placed in 100 ml flask well dried. To this, 70 ml chloroform was added.
To the phosgene/toluene solution maintained at -30 'C, the (R)-3-acetoxy-2-(Z-pyridyl) propanol solution was dropwise added with a double-ended needle. Following the completion of addition, thin layer chromatography was executed to know whether the starting materials were completely exhausted. Then, the reaction system was cooled to -70 'C and slowly added with 50 g of liquid ammonia. Reaction proceeded at -70 'C while stirring.
Excess ammonia present in the reaction mixture was blown off by nitrogen gas at about 2 hours after the completion of reaction. While precipitate was filtered off and the W O 96109283 y ,, . j ~ ~ 7 6 ~ 6 p PCT/HIt95/0012~1 solvents, toluene and chloroform, were removed by use of a rotary evaporator.
The resultant concentrated solution was subjected to column chromatography (mobile phase: ethyl acetate), 5 giving forth (S)-3-acetoxy-2-(2-pyridyl) propanol carbamate: Yield 84.0 $, purity 99.8 $.
Physical Properties of (S)-3-acetoxy-2-(2-pyridyl) propanol carbamate: [a] _ + 45.3 ' (0.42 in acetone) 1H-NMR (CDC13, 200 MHz), ppm (b): 1.99 (s, 3H), 3.52 10 (q, IH), 4.43(m, 4H), 5.25 (br, 2H), 7.21(m, 2H), 7.68(m, 1H), 8.56(d, 1H) EXAMPLE II
(S)-3-Acetoxy-2-(2-(3-chloro)pyridyl) propanol carbamate The title compound was prepared in a similar manner to that of Example I, except that (R)-3-acetoxy-2-(2-(3-chloro)pyridyl) propanol, instead of (R)-3-acetoxy-2-(2-pyridyl) propanol, was used as a starting material: Yield 68.3$. Purity 98.5 $.
[aJ = + 53.1 ' (0.50 in acetone) EXAMPLE III
(S)-3-Acetoxy-2-(Z-(3-trifluoromethyl)pyridyl) propanol carbamate W O 96109283 ~ 1 T 6 9 6 0 PCT~~00124 The title compound was prepared in a similar manner ' to that of Example I, except that (R)-3-acetoxy-2-(2-(3-trifluoromethyl)pyridyl) propanol, instead of (R)-3 acetoxy-2-(2-pyridyl) propanol, was used as a starting material: Yield 63.2%. Purity 99.3 %.
[a] _ + 24.7 ° (0.50 in acetone) EXAMPLE IV
(S)-3-Acetoxy-2-(2-(3-methyl)pyridyl) propanol carbamate The title compound was prepared in a similar manner to that of Example I, except that (R)-3-acetoxy-2-(2-(3-methyl)pyridyl) propanol, instead of (R)-3-acetoxy-2-(2-pyridyl) propanol, was used as a starting material: Yield 76.8 %. Purity 99.3 %.
[o] _ + 15.3 ° (0.50 in acetone) EXAMPLE V
(S)-3-Acetoxy-2-(2-(3-thiomethyl)pyridyl) propanol carbamate Except that (R)-3-acetoxy-2-(2-(3-thiomethyl)pyridyl) propanol, instead of (R)-3-acetoxy-2-(2-pyridyl) propanol, was used as a starting material, Example I was repeated to give the title compound: Yield 67.3%. Purity 99.1 %.
WO 96!09283 ~ ~ , :' . ... 'c y. 217 6 9 6 0 PCT~5100124 [a] _ + 37.8 ' (0.50 in acetone) r EXAMPLE VI
(S)-3-Acetoxy-2-(2-(4,6-dichloro)pyridyl) propanol carbamate Except that (R)-3-acetoxy-Z-(2-(4,6-dichloro)pyridyl) propanol, instead of (R)-3-acetoxy-2-(2-pyridyl) propanol, was used as a starting material, Example I was repeated to give the title compound: Yield 70.1 %. Purity 99.2 %.
[a] _ + 48.3 ' (0.50 in acetone) EXAMPLE VII
(S)-3-Acetoxy-Z-(2-(4,6-dimethoxy)pyridyl) propanol carbamate Except that (R)-3-acetoxy-2-(2-(4,6-dimethoxy)pyridyl) propanol, instead of (R)-3-acetoxy-2-(2-pyridyl) propanol, was used as a starting material, Example I was repeated to give the title compound: Yield 72.9 %. Purity 98.9 %.
[n] _ + 24.1 ' (0.50 in acetone) WO 96/09283 ~, . . , 217 b 9 6 Q PCT~S100124 EXAMPLE VIII
(S)-3-Acetoxy-2-phenylpropanol carbamate In a Z50 mL flask equipped with a magnetic stirrer, 4.7 g of antipyrine (0.025 mole) and 1.94 g of (R)-3-acetoxy-2-phenylpropanol (0.01 mole) were placed. 80 mL
of toluene and ZO mL of chloroform were poured into the flask. The resulting reaction solution was maintained at 0 'C while stirring.
To the solution, 14 mL of 0.6 M phosgene was added at 0 'C while stirring. White precipitate was evidence that the reaction Was making progress. After five hours, the reaction was terminated, and the reaction mixture was subjected to filtration.
The filtrate was maintained at 0 'C and ammonia gas was flowed into the flask for 30 minutes. After being stirred for 30 minutes, the mixture was filtered to remove precipitate. The solvents used were distilled off in vacuo.
Isolation by column chromatography (using ethyl acetate and n-hexane (1:1) as the mobile phase) gave (S)-3-acetoxy-2-phenylpropanol carbamate: Yield 87.2 %. Purity 99.2 %.
Physical properties of (S)-3-acetoxy-2-phenylpropanol carbamate: [a) _ + 2.5 ' (0.03 in CHC13) ZS 1H-NMR (CDC13, 200 MHz), ppm (5): 1.99(s, 3H), 3.21-WO 96109283 ~, , ~~ ~ -~ := 2 ~ 7 6 9 6 0 P~~SID0124 3.37(m, 1H), 4.21-4.38(m, 4H), 5.14(b, ZH), 7.21-7.30(m, 5H) EXAMPLE IX
(S)-3-Acetoxy-2-(o-chlorophenyl)propanol carbamate The title compound was synthesized in a similar manner to that of Example VIII, except that (R)-3-acetoxy-2-(o-chlorophenyl) propanol, instead of (R)-3-acetoxy-2-phenyl propanol, Was used as a starting material. Yield 63.1 %.,Purity 99.3 %.
[a] _ + 13.7 ' (0.50 in methanol) EXAMPLE X
(S)-3-Acetoxy-2-(o-trifluoromethylphenyl)propanol carbamate The title compound was synthesized in a similar manner to that of Example VIII, except that (R)-3-acetoxy-2-(o-trifluoromethyl phenyl) propanol, instead of (R)-3-acetoxy-2-phenyl propanol, was used as a starting material. Yield 63.1 %. Purity 99.6 %.
[a] _ + 32.5 ° (0.50 in methanol) WO 96109283 _ 217 b 9 6 0 PCT/KR95100114 EXAMPLE XI
(S)-3-Acetoxy-2-(o-methylphenyl)propanol carbamate The title compound was synthesized in a similar manner to that of Example VIII, except that (R)-3-acetoxy-5 2-(o-methylphenyl) propanol, instead of (R)-3-acetoxy-2-phenyl propanol, was used as a starting material. Yield 78.7 %. Purity 98.5 %.
[a] _ + 8.3 ' (0.50 in methanol) EXAMPLE XII
10 (S)-3-Acetoxy-2-(o-thiomethylphenyl) propanol carbamate The title compound was synthesized in a similar manner to that of Example VIII, except that (R)-3-acetoxy 2-(o-thiomethylphenyl) propanol, instead of (R)-3-acetoxy 2-phenyl propanol, was used as a starting material. Yield 15 60.3 %. Purity 99.4 %.
[a] _ + 21.9 ' (0.50 in methanol) EXAMPLE XIII
(S)-3-Acetoxy-2-(2,4-dicholrophenyl) propanol carbamate Except that (R)-3-acetoxy-2-(2,4-dichlorophenyl) WO 96/09283 . ~ ~ T ~ g 6 ~ PCT/IiR95/00124 propanol, instead of (R)-3-acetoxy-2-phenyl propanol, was used as a starting material,-Example VIII was repeated to give the title compound. Yield 67.5 $. Purity 99.7 ~.
[a] _ + 21.7 ° (0.50 in methanol) EXAMPLE XIV
(S)-3-Acetoxy-2-(2,4-dimethoxyphenyl) propanol carbamate Except that (R)-3-acetoxy-2-(2,4-dimethoxyphenyl) propanol, instead of (R)-3-acetoxy-2-phenyl propanol, was used as a starting material, Example VIII was repeated to give the title compound. Yield 63.0 ~. Purity 99.1 ~.
[a] _ + 12.4 ' (0.50 inmethanol) EXAMPLE XV
(S)-2-(2-pyridyl)-1,3-propanediol monocarbamate In a well dried 250 mL flask, 1.0 g of (S)-3-acetoxy-2-(2-pyridyl)propanol carbamate obtained in Example I was placed with 200 mL of 0.05 M phosphate buffer solution (pH
7) and 1.1 g of PLE-A and then, the resulting mixture was vigorously stirred at a roomtemperature for five hours.
Subsequently, 200 mL of ethyl acetate was added to the well stirred mixture, for solvent extraction. This extraction was repeated three times.
The ethyl acetate solution obtained was dried over anhydrous magnesium sulfate. A rotary evaporator was used to remove extra ethyl acetate. Isolation by column chromatography gave (S)-2-(2-pyridyi)-1,3-propanediol monocarbamate: Yield 60.0 %. Purity 99.5 %.
Physical properties of (S)-2-(2-pyridyl)-1,3-propanediol carbamate: [a] _ + 24.1 ' (0.30 in acetone) iH-NMR (CDC13, 200 MHz), ppm (b): 3.21(s, 1H), 3.66(m, 2H), 4.30(m,2H), 6.43(br, 2H), 7.31(m, 2H), 7.76(m, 1H), 8.53(d, 1H) EBAMPLE XVI
(S)-2-(2-(3-Chloro)pyridyl)-1,3-propanediol monocarbamate Except for using (S)-3-acetoxy-2-(2-(3-cholro)pyridyl)propanol carbamate, instead of (S)-3-acetoxy-2-(2-pyridyl.)propanol carbamate, as a starting material, Example XV was repeated to give the title compound: Yield 57.3 %. Purity 99.8 %.
[a] = t 27.8 ' (0.5D in methanol) EXAMPLE XViI
(S)-2-(2-(3-Trifluoromethyl)pyridyl)-1,3-propanediol monocarbamate WO 96109283 217 6 9 b 0 PCT~S/0012d ' ! ~ a Except for using (S)-3-acetoxy-2-(2-(3-trifluoromethyl)pyridyl)propanol carbamate, instead of (S)-3-acetoxy-2-(2-pyridyi)propanol carbamate, as a starting material, Example XV was repeated to give the S title compound: Yield 63.2 %. Purity 99.3 %.
(a] _ + 3.5 ° (0.50 in methanol) EXAMPLE XVIII
(S)-2-(2-(3-Methyl)pyridyl)-1,3-propanediol monocarbamate Except for using (S)-3-acetoxy-2-(2-(3-methyl)pyridyl)propanol carbamate, instead of (S)-3-acetoxy-2-(2-pyridyl)propanol carbamate, as a starting material, Example XV was repeated .to give the title compound: Yield 72.8 %. Purity 98.7 %.
[a] _ + 8.7 ' (0.50 in methanol) EXAMPLE XIX
(S)-2-(2-(3-Thiomethyl)pyridyl)-1,3-propanediol monocarbamate Except for using (S)-3-acetoxy-2-(2-(3-thiomethyl)pyridyl)propanoi carbamate, instead of (S)-3-acetoxy-2-(2-pyridyl)propanol carbamate, as a starting material, Example.XV was repeated to give the title WO 96109283 F 217 6 9 6 Q PCT~5100124 compound: Yield 67.5 %. Purity 99.5 %.
' [a] _ + 20.4 ° (0.50 in methanol) EXAMPLE XX
(S)-Z-(2-(4,6-dichloro)pyridyl)-1,3-propanediol monocarbamate The title compound was synthesized in a similar manner to that of Example XV, except that (S)-3-acetoxy-2-(2-(4,6-dichloro)pyridyl)propanol carbamate, instead of (S)-3-acetoxy-2-(2-pyridyl)propanol carbamate, was used as a starting material. Yield 60.5 %. Purity 99.5 %.
[a] _ + 33.1 ' (0.50 in methanol) EXAMPLE XXI
(S)-2-(2-(4,6-dimethoxy)pyridyl)-1,3-propanediol monocarbamate The title compound was synthesized in a similar manner to that of Example XV, except that (S)-3-acetoxy-2-(2-(4,6-dimethoxy)pyridyl)propanol carbamate, instead of (S)-3-acetoxy-2-(2-pyridyl) propanol carbamate, was used as a starting material. Yield 70.4 %. Purity 99.5 %.
[a] _ + 11.8 ° (0.50 in methanol) WO 96109283 G, .:.:. 217 6 9 6 p P'T'~'~S~oorz~ ~
EXAMPLE XXII
(S)-2-Phenyl-1,3-propanediol monocarbamate In a 500 mL flask equipped with a magnetic stirrer, 2.37 g of (S)-3-acetoxy-2-phenylpropanol carbamate (0.01 5 mole) obtained in Example VIII was placed and 200 mL of phosphate buffer solution (0.014 mole, pH 7) and 1.2 g of PLE-A were added. The reaction mixture was stirred at room temperature.
When the conversion rate of (S)-3-acetoxy-2 10 phenylpropanol carbamate reached 90 %, which was detected by HPLC, the reaction was stopped and the resulting mixture was filtered. The filtrate was extracted three times with ethyl acetate, to isolate an organic layer of which the extra solvent was then distilled off by a rotary I5 evaporator. Isolation by column chromatography using a mixture of ethyl acetate and n-hexane (1:1) as the mobile phase gave (S)-2-phenyl-1,3-propanediol monocarbamate:
Yield 70.1 %. Purity 99.7 %.
Physical properties of (S)-2-phenyl-1,3-propanediol 20 monocarbamate: [c] = f 1.8 ' (0.03 in ethanol) 1H-NMR (CDC13, 200 MHz), ppm (b): 2.49-2.63(m, 1H), 2.95-3.21(m, IH), 3.75-3.88(m, ZH), 4.37(d, 2H), 4.91(b, 2H), 7.21-7.36(m, 5H) WO 96/09283 ~ 2 l 7 6 9 6 Q P~~S/00124 EXAMPLE XXIII
v (S)-2-(o-Chlorophenyl)-1,3-propanediol monocarbamate The title compound was synthesized in a similar manner to that of Example XXII, except that (S)-3-acetoxy-2-(o-cholrophenyl)propanol carbamate, instead of (S)-3-acetoxy-2-phenylpropanol carbamate, was used as a starting material. Yield 76.3 %. Purity 99.3 %.
[a] _ + 8.7 ' (0.50 in methanol) EXAMPLE XXIV
(S)-2-(o-Trifluoromethylphenyl)-1,3-propanediol monocarbamate The title compound was synthesized in a similar manner to that of Example XXII, except that (S)-3-acetoxy-2-(o-trifluoromethylphenyl)propanol carbamate, instead of (S)-3-acetoxy-2-phenylpropanoi carbamate, was used as a starting material. Yield 63.5 %. Purity 99.4 %.
[Q] _ + 21.3 ' (0.50 in methanol) EXAMPLE XXV
(S)-2-(o-methylphenyl)-1,3-propanediol monocarbamate WO 9Gl09283 217 6 9 6 fl PCT/KR95/00124 The title compound was synthesized in a similar manner to that of Example XXII, except that (S)-3-acetoxy-2-(o-methylphenyl)propanol carbamate, instead of (S)-3-acetoxy-2-phenylpropanol carbamate, was used as a starting material. Yield 78.3 %. Purity 99.0 %.
[a] = t 5.2 ' (0.50 in methanol) EXAMPLE XXVI
(S)-2-(o-Thiomethylphenyl)-1,3-propanediol monocarbamate The title compound was synthesized in a similar manner to that of Example XXII, except that (S)-3-acetoxy-2-(o-thiomethyiphenyl)propanol carbamate, instead of (S)-3-acetoxy-2-phenylpropanol carbamate, was used as a starting material. Yield 75.7 %. Purity 98.7 %.
[a] _ + 18.2 ' (0.50 in methanol) EXAMPLE XXVII
(S)-2-(2,4-Dichlorophenyl)-1,3-propanediol monocarbamate The title compound was synthesized in a similar manner to that of Example XXII, except that (S)-3-acetoxy-2-(2,4-dichlorophenyl)propanol carbamate, instead of (S)-3-acetoxy-2-phenylpropanol carbamate, was used as a starting material. Yield 78.9 %. Purity 99.7 %.
W096109283 " - PCTlKR95100124 [a] _ + 18.0 ' (0.50 in methanol) EXAMPLE XXVIII
(S)-2-(2,4-dimethoxyphenyl)-1,3-propanediol monocarbamate The title compound was synthesized in a similar manner to that of Example XXII, except that (S)-3-acetoxy-2-(2,4-dimethoxyphenyl)propanol carbamate, instead of (S)-3-acetoxy-2-phenylpropanol carbamate, was used as a starting material. Yield 65.3 ~. Purity 99.2 ~.
[a] _ + 25.1 ' (0.50 in methanol) Other features, advantages and embodiments of the present invention disclosed herein will be readily apparent to those exercising ordinary skill after reading the foregoing disclosures. In this regard, while specific embodiments of the invention have been described in considerable detail, variations and modifications of these embodiments can be effected without departing from the spirit and scope of the invention as described and claimed.
Temperature is maintained at -30 to 0 'C upon reaction with phosgene while the reaction with anhydrous ammonia is carried out at a temperature of -70 to 0 'C.
For use, anhydrous ammonia is condensed to a liquid.
It is added at an excess of 10 to 100 equivalents and preferably at an excess of 25 to 50 equivalents.
In accordance with the present invention, the compound of Formula I can be converted from (S)-3-acetoxy-2-aryl-propanol carbamate, represented by Formula II, through the catalytic reaction of hydrolase in a buffer solution. High yield and optical purity can be accomplished within a short time by the enzymatic hydrolysis of (S)-3-acetoxy-2-aryl-propanol carbamate into (S)-2-aryl-1,3-propanediol monocarbamate.
Generally, enzymes show a far higher catalytic activity than chemical catalysts while giving less by-products.--In addition, since the enzymatic conversion of (S)-3-acetoxy-2-arylpropanol carbamate into (S)-2-aryl-1,3-propanediol monocarbamate is carried out at a low WO 96109283 t ' y ~ 2 l 7 6 9 6 0 PCT/KR95100124 temperature in a neutral aqueous solution, for example, phosphate buffer solution, the side-reactions attributable ' to the enzyme can be eliminated. Following the hydrolysis, the enzyme used can be almost completely removed only by filtration without lowering the product yield. Accordingly, the present invention is very advantageous in time and cost.
In more detail, the (S)-3-acetoxy-2-arylpropanol carbamate of Formula II is dissolved in a phosphate buffer solution and then, vigorously stirred at a temperature of 0 to 35 'C and with ordinary pressure in the presence of hydrolase. Preference is given to a temperature of 10 to 25 'C. Care must be taken to control the reaction temperature. A reaction temperature of higher than 35 'C
makes the hydrolysis proceed faster but causes the enzyme to be lowered in selectivity, deleteriously affecting the optical purity of the product.
The phosphate buffer solution has a pH ranging from 6 to 9 with a preference of 7. For example, if the phosphate buffer solution has a pH of higher or lower than 7, the optical purity of the product becomes poor. In order for the selectivity of the enzyme not to be lowered, the phosphate buffer solution is preferably diluted into 0.01 to 0.1 mole solution.
With regard to the hydrolase used for the conversion, various sources are available. Representative examples include lipase extracted from pig's pancreas (PPL), WO 96109283 217 6 9 6 0 PCT/KR9510012.1 Candida lipase (CCL), Aspagillus lipase (ANL), Pseudomona5 ' lipase (PSL) and an esterase from pig's liver (PLE), with a preference for PLE.
Usually at 4 to 5 hours after adding the enzyme, the conversion reaction of (S)-3-acetoxy-2-aryl-propanol carbamate into (S)-2-aryl-1,3-propanediol monocarbamate is terminated. Thin layer chromatography or high performance liquid chromatography may be used to determine the termination point of the conversion reaction.
From the resultant reaction mixture, the enzyme may be filtered off simply and then, the solvent is removed by using a rotary evaporator. Purification by column chromatography gives (S)-2-aryl-1,3-propanediol monocarbamate of Formula I, a novel compound.
Likewise, (R)-3-acetoxy-2-aryl-propanol of Formula III can be prepared by use of an enzyme. For this, PPL, CCL or PSL is immobilized to cellite. Preference is given to PPL and PSL_ 2-aryl-1,3-propanediol is dissolved in anhydrous alkyl acetate, such as methyl acetate, ethyl acetate, propyl acetate and vinyl acetate, or anhydrous alkenyl acetate and incubated at a temperature of -10 to 35 'C. Following this, the reactant is added with the immobilized catalyst system in the absence of solvent while vigorously stirring. At this moment, the reaction is carried out preferably at a temperature of 0 to 35 'C
under ordinary pressure. Particularly, care must be taken to control the temperature below 35 'C because higher W O 96/09283 , ; ~ ; ' _ 2 ~ 7 6 9 6 0 PCTIKR95100124 temperature makes the reaction proceed too fast, resulting in degradation of optical purity.
High performance liquid chromatography can also be used about 3 hours-after the reaction, to determine the termination of the reaction. Five hours after the reaction is usual-ly enough to obtain the compound of Formula III with a yield of 85 % or larger and an optical purity of 99 % or more.
To identify (S)-2-aryl-1,3-propanediol monocarbamate as a pharmaceutically useful material, anticonvulsant activity assay of the novel compound of the present invention was executed through standard Maximal Electro Shock (MES) test. To the end, 0.5 g (S)-2-phenyl-1,3 propanediol monocarbamate was suspended in 100 ml buffer solution at pH 7.4. The prepared suspension was administered into ten male CD-2 mice weighing about 20 to g at a dose of 300 mg/kg. Oral administration through a syringe is preferred. At one hour after administration, the middle of the forehead of the mice was electrically 20 shocked at 50 mA for 0.2 second by use of corneal electrode. Of the ten mice administered with the compound of the present invention, nine were not convulsed and acted as usual_ Only one was convulsed. to death.
A better understanding of the present invention may 25 be obtained in light of following examples which are set forth to illustrate, and are not to be construed to limit, the present invention.
WO 96/09283 ~ 21 l 6 9 6 0 PCTJKR95/00124 EXAMPLE I
(S)-3-Acetoxy-Z-(2-pyridyl) propanol carbamate 500 ml flask equipped with a thermometer was well dried and purged by flowing nitrogen gas into the inside thereof for 30 min. After the moisture and air present within the flask was replaced by nitrogen gas, 24.5 mI of 0.6 M phosgene solution was placed in the purged flask, followed by the addition of 150 mI of toluene. The flask was maintained at -30 'C in a bath containing dry ice and acetone.
Separately, 2.0 g of (R}-3-acetoxy-2-(2-pyridyl)propanol and 4.7 g of antipyrine were placed in 100 ml flask well dried. To this, 70 ml chloroform was added.
To the phosgene/toluene solution maintained at -30 'C, the (R)-3-acetoxy-2-(Z-pyridyl) propanol solution was dropwise added with a double-ended needle. Following the completion of addition, thin layer chromatography was executed to know whether the starting materials were completely exhausted. Then, the reaction system was cooled to -70 'C and slowly added with 50 g of liquid ammonia. Reaction proceeded at -70 'C while stirring.
Excess ammonia present in the reaction mixture was blown off by nitrogen gas at about 2 hours after the completion of reaction. While precipitate was filtered off and the W O 96109283 y ,, . j ~ ~ 7 6 ~ 6 p PCT/HIt95/0012~1 solvents, toluene and chloroform, were removed by use of a rotary evaporator.
The resultant concentrated solution was subjected to column chromatography (mobile phase: ethyl acetate), 5 giving forth (S)-3-acetoxy-2-(2-pyridyl) propanol carbamate: Yield 84.0 $, purity 99.8 $.
Physical Properties of (S)-3-acetoxy-2-(2-pyridyl) propanol carbamate: [a] _ + 45.3 ' (0.42 in acetone) 1H-NMR (CDC13, 200 MHz), ppm (b): 1.99 (s, 3H), 3.52 10 (q, IH), 4.43(m, 4H), 5.25 (br, 2H), 7.21(m, 2H), 7.68(m, 1H), 8.56(d, 1H) EXAMPLE II
(S)-3-Acetoxy-2-(2-(3-chloro)pyridyl) propanol carbamate The title compound was prepared in a similar manner to that of Example I, except that (R)-3-acetoxy-2-(2-(3-chloro)pyridyl) propanol, instead of (R)-3-acetoxy-2-(2-pyridyl) propanol, was used as a starting material: Yield 68.3$. Purity 98.5 $.
[aJ = + 53.1 ' (0.50 in acetone) EXAMPLE III
(S)-3-Acetoxy-2-(Z-(3-trifluoromethyl)pyridyl) propanol carbamate W O 96109283 ~ 1 T 6 9 6 0 PCT~~00124 The title compound was prepared in a similar manner ' to that of Example I, except that (R)-3-acetoxy-2-(2-(3-trifluoromethyl)pyridyl) propanol, instead of (R)-3 acetoxy-2-(2-pyridyl) propanol, was used as a starting material: Yield 63.2%. Purity 99.3 %.
[a] _ + 24.7 ° (0.50 in acetone) EXAMPLE IV
(S)-3-Acetoxy-2-(2-(3-methyl)pyridyl) propanol carbamate The title compound was prepared in a similar manner to that of Example I, except that (R)-3-acetoxy-2-(2-(3-methyl)pyridyl) propanol, instead of (R)-3-acetoxy-2-(2-pyridyl) propanol, was used as a starting material: Yield 76.8 %. Purity 99.3 %.
[o] _ + 15.3 ° (0.50 in acetone) EXAMPLE V
(S)-3-Acetoxy-2-(2-(3-thiomethyl)pyridyl) propanol carbamate Except that (R)-3-acetoxy-2-(2-(3-thiomethyl)pyridyl) propanol, instead of (R)-3-acetoxy-2-(2-pyridyl) propanol, was used as a starting material, Example I was repeated to give the title compound: Yield 67.3%. Purity 99.1 %.
WO 96!09283 ~ ~ , :' . ... 'c y. 217 6 9 6 0 PCT~5100124 [a] _ + 37.8 ' (0.50 in acetone) r EXAMPLE VI
(S)-3-Acetoxy-2-(2-(4,6-dichloro)pyridyl) propanol carbamate Except that (R)-3-acetoxy-Z-(2-(4,6-dichloro)pyridyl) propanol, instead of (R)-3-acetoxy-2-(2-pyridyl) propanol, was used as a starting material, Example I was repeated to give the title compound: Yield 70.1 %. Purity 99.2 %.
[a] _ + 48.3 ' (0.50 in acetone) EXAMPLE VII
(S)-3-Acetoxy-Z-(2-(4,6-dimethoxy)pyridyl) propanol carbamate Except that (R)-3-acetoxy-2-(2-(4,6-dimethoxy)pyridyl) propanol, instead of (R)-3-acetoxy-2-(2-pyridyl) propanol, was used as a starting material, Example I was repeated to give the title compound: Yield 72.9 %. Purity 98.9 %.
[n] _ + 24.1 ' (0.50 in acetone) WO 96/09283 ~, . . , 217 b 9 6 Q PCT~S100124 EXAMPLE VIII
(S)-3-Acetoxy-2-phenylpropanol carbamate In a Z50 mL flask equipped with a magnetic stirrer, 4.7 g of antipyrine (0.025 mole) and 1.94 g of (R)-3-acetoxy-2-phenylpropanol (0.01 mole) were placed. 80 mL
of toluene and ZO mL of chloroform were poured into the flask. The resulting reaction solution was maintained at 0 'C while stirring.
To the solution, 14 mL of 0.6 M phosgene was added at 0 'C while stirring. White precipitate was evidence that the reaction Was making progress. After five hours, the reaction was terminated, and the reaction mixture was subjected to filtration.
The filtrate was maintained at 0 'C and ammonia gas was flowed into the flask for 30 minutes. After being stirred for 30 minutes, the mixture was filtered to remove precipitate. The solvents used were distilled off in vacuo.
Isolation by column chromatography (using ethyl acetate and n-hexane (1:1) as the mobile phase) gave (S)-3-acetoxy-2-phenylpropanol carbamate: Yield 87.2 %. Purity 99.2 %.
Physical properties of (S)-3-acetoxy-2-phenylpropanol carbamate: [a) _ + 2.5 ' (0.03 in CHC13) ZS 1H-NMR (CDC13, 200 MHz), ppm (5): 1.99(s, 3H), 3.21-WO 96109283 ~, , ~~ ~ -~ := 2 ~ 7 6 9 6 0 P~~SID0124 3.37(m, 1H), 4.21-4.38(m, 4H), 5.14(b, ZH), 7.21-7.30(m, 5H) EXAMPLE IX
(S)-3-Acetoxy-2-(o-chlorophenyl)propanol carbamate The title compound was synthesized in a similar manner to that of Example VIII, except that (R)-3-acetoxy-2-(o-chlorophenyl) propanol, instead of (R)-3-acetoxy-2-phenyl propanol, Was used as a starting material. Yield 63.1 %.,Purity 99.3 %.
[a] _ + 13.7 ' (0.50 in methanol) EXAMPLE X
(S)-3-Acetoxy-2-(o-trifluoromethylphenyl)propanol carbamate The title compound was synthesized in a similar manner to that of Example VIII, except that (R)-3-acetoxy-2-(o-trifluoromethyl phenyl) propanol, instead of (R)-3-acetoxy-2-phenyl propanol, was used as a starting material. Yield 63.1 %. Purity 99.6 %.
[a] _ + 32.5 ° (0.50 in methanol) WO 96109283 _ 217 b 9 6 0 PCT/KR95100114 EXAMPLE XI
(S)-3-Acetoxy-2-(o-methylphenyl)propanol carbamate The title compound was synthesized in a similar manner to that of Example VIII, except that (R)-3-acetoxy-5 2-(o-methylphenyl) propanol, instead of (R)-3-acetoxy-2-phenyl propanol, was used as a starting material. Yield 78.7 %. Purity 98.5 %.
[a] _ + 8.3 ' (0.50 in methanol) EXAMPLE XII
10 (S)-3-Acetoxy-2-(o-thiomethylphenyl) propanol carbamate The title compound was synthesized in a similar manner to that of Example VIII, except that (R)-3-acetoxy 2-(o-thiomethylphenyl) propanol, instead of (R)-3-acetoxy 2-phenyl propanol, was used as a starting material. Yield 15 60.3 %. Purity 99.4 %.
[a] _ + 21.9 ' (0.50 in methanol) EXAMPLE XIII
(S)-3-Acetoxy-2-(2,4-dicholrophenyl) propanol carbamate Except that (R)-3-acetoxy-2-(2,4-dichlorophenyl) WO 96/09283 . ~ ~ T ~ g 6 ~ PCT/IiR95/00124 propanol, instead of (R)-3-acetoxy-2-phenyl propanol, was used as a starting material,-Example VIII was repeated to give the title compound. Yield 67.5 $. Purity 99.7 ~.
[a] _ + 21.7 ° (0.50 in methanol) EXAMPLE XIV
(S)-3-Acetoxy-2-(2,4-dimethoxyphenyl) propanol carbamate Except that (R)-3-acetoxy-2-(2,4-dimethoxyphenyl) propanol, instead of (R)-3-acetoxy-2-phenyl propanol, was used as a starting material, Example VIII was repeated to give the title compound. Yield 63.0 ~. Purity 99.1 ~.
[a] _ + 12.4 ' (0.50 inmethanol) EXAMPLE XV
(S)-2-(2-pyridyl)-1,3-propanediol monocarbamate In a well dried 250 mL flask, 1.0 g of (S)-3-acetoxy-2-(2-pyridyl)propanol carbamate obtained in Example I was placed with 200 mL of 0.05 M phosphate buffer solution (pH
7) and 1.1 g of PLE-A and then, the resulting mixture was vigorously stirred at a roomtemperature for five hours.
Subsequently, 200 mL of ethyl acetate was added to the well stirred mixture, for solvent extraction. This extraction was repeated three times.
The ethyl acetate solution obtained was dried over anhydrous magnesium sulfate. A rotary evaporator was used to remove extra ethyl acetate. Isolation by column chromatography gave (S)-2-(2-pyridyi)-1,3-propanediol monocarbamate: Yield 60.0 %. Purity 99.5 %.
Physical properties of (S)-2-(2-pyridyl)-1,3-propanediol carbamate: [a] _ + 24.1 ' (0.30 in acetone) iH-NMR (CDC13, 200 MHz), ppm (b): 3.21(s, 1H), 3.66(m, 2H), 4.30(m,2H), 6.43(br, 2H), 7.31(m, 2H), 7.76(m, 1H), 8.53(d, 1H) EBAMPLE XVI
(S)-2-(2-(3-Chloro)pyridyl)-1,3-propanediol monocarbamate Except for using (S)-3-acetoxy-2-(2-(3-cholro)pyridyl)propanol carbamate, instead of (S)-3-acetoxy-2-(2-pyridyl.)propanol carbamate, as a starting material, Example XV was repeated to give the title compound: Yield 57.3 %. Purity 99.8 %.
[a] = t 27.8 ' (0.5D in methanol) EXAMPLE XViI
(S)-2-(2-(3-Trifluoromethyl)pyridyl)-1,3-propanediol monocarbamate WO 96109283 217 6 9 b 0 PCT~S/0012d ' ! ~ a Except for using (S)-3-acetoxy-2-(2-(3-trifluoromethyl)pyridyl)propanol carbamate, instead of (S)-3-acetoxy-2-(2-pyridyi)propanol carbamate, as a starting material, Example XV was repeated to give the S title compound: Yield 63.2 %. Purity 99.3 %.
(a] _ + 3.5 ° (0.50 in methanol) EXAMPLE XVIII
(S)-2-(2-(3-Methyl)pyridyl)-1,3-propanediol monocarbamate Except for using (S)-3-acetoxy-2-(2-(3-methyl)pyridyl)propanol carbamate, instead of (S)-3-acetoxy-2-(2-pyridyl)propanol carbamate, as a starting material, Example XV was repeated .to give the title compound: Yield 72.8 %. Purity 98.7 %.
[a] _ + 8.7 ' (0.50 in methanol) EXAMPLE XIX
(S)-2-(2-(3-Thiomethyl)pyridyl)-1,3-propanediol monocarbamate Except for using (S)-3-acetoxy-2-(2-(3-thiomethyl)pyridyl)propanoi carbamate, instead of (S)-3-acetoxy-2-(2-pyridyl)propanol carbamate, as a starting material, Example.XV was repeated to give the title WO 96109283 F 217 6 9 6 Q PCT~5100124 compound: Yield 67.5 %. Purity 99.5 %.
' [a] _ + 20.4 ° (0.50 in methanol) EXAMPLE XX
(S)-Z-(2-(4,6-dichloro)pyridyl)-1,3-propanediol monocarbamate The title compound was synthesized in a similar manner to that of Example XV, except that (S)-3-acetoxy-2-(2-(4,6-dichloro)pyridyl)propanol carbamate, instead of (S)-3-acetoxy-2-(2-pyridyl)propanol carbamate, was used as a starting material. Yield 60.5 %. Purity 99.5 %.
[a] _ + 33.1 ' (0.50 in methanol) EXAMPLE XXI
(S)-2-(2-(4,6-dimethoxy)pyridyl)-1,3-propanediol monocarbamate The title compound was synthesized in a similar manner to that of Example XV, except that (S)-3-acetoxy-2-(2-(4,6-dimethoxy)pyridyl)propanol carbamate, instead of (S)-3-acetoxy-2-(2-pyridyl) propanol carbamate, was used as a starting material. Yield 70.4 %. Purity 99.5 %.
[a] _ + 11.8 ° (0.50 in methanol) WO 96109283 G, .:.:. 217 6 9 6 p P'T'~'~S~oorz~ ~
EXAMPLE XXII
(S)-2-Phenyl-1,3-propanediol monocarbamate In a 500 mL flask equipped with a magnetic stirrer, 2.37 g of (S)-3-acetoxy-2-phenylpropanol carbamate (0.01 5 mole) obtained in Example VIII was placed and 200 mL of phosphate buffer solution (0.014 mole, pH 7) and 1.2 g of PLE-A were added. The reaction mixture was stirred at room temperature.
When the conversion rate of (S)-3-acetoxy-2 10 phenylpropanol carbamate reached 90 %, which was detected by HPLC, the reaction was stopped and the resulting mixture was filtered. The filtrate was extracted three times with ethyl acetate, to isolate an organic layer of which the extra solvent was then distilled off by a rotary I5 evaporator. Isolation by column chromatography using a mixture of ethyl acetate and n-hexane (1:1) as the mobile phase gave (S)-2-phenyl-1,3-propanediol monocarbamate:
Yield 70.1 %. Purity 99.7 %.
Physical properties of (S)-2-phenyl-1,3-propanediol 20 monocarbamate: [c] = f 1.8 ' (0.03 in ethanol) 1H-NMR (CDC13, 200 MHz), ppm (b): 2.49-2.63(m, 1H), 2.95-3.21(m, IH), 3.75-3.88(m, ZH), 4.37(d, 2H), 4.91(b, 2H), 7.21-7.36(m, 5H) WO 96/09283 ~ 2 l 7 6 9 6 Q P~~S/00124 EXAMPLE XXIII
v (S)-2-(o-Chlorophenyl)-1,3-propanediol monocarbamate The title compound was synthesized in a similar manner to that of Example XXII, except that (S)-3-acetoxy-2-(o-cholrophenyl)propanol carbamate, instead of (S)-3-acetoxy-2-phenylpropanol carbamate, was used as a starting material. Yield 76.3 %. Purity 99.3 %.
[a] _ + 8.7 ' (0.50 in methanol) EXAMPLE XXIV
(S)-2-(o-Trifluoromethylphenyl)-1,3-propanediol monocarbamate The title compound was synthesized in a similar manner to that of Example XXII, except that (S)-3-acetoxy-2-(o-trifluoromethylphenyl)propanol carbamate, instead of (S)-3-acetoxy-2-phenylpropanoi carbamate, was used as a starting material. Yield 63.5 %. Purity 99.4 %.
[Q] _ + 21.3 ' (0.50 in methanol) EXAMPLE XXV
(S)-2-(o-methylphenyl)-1,3-propanediol monocarbamate WO 9Gl09283 217 6 9 6 fl PCT/KR95/00124 The title compound was synthesized in a similar manner to that of Example XXII, except that (S)-3-acetoxy-2-(o-methylphenyl)propanol carbamate, instead of (S)-3-acetoxy-2-phenylpropanol carbamate, was used as a starting material. Yield 78.3 %. Purity 99.0 %.
[a] = t 5.2 ' (0.50 in methanol) EXAMPLE XXVI
(S)-2-(o-Thiomethylphenyl)-1,3-propanediol monocarbamate The title compound was synthesized in a similar manner to that of Example XXII, except that (S)-3-acetoxy-2-(o-thiomethyiphenyl)propanol carbamate, instead of (S)-3-acetoxy-2-phenylpropanol carbamate, was used as a starting material. Yield 75.7 %. Purity 98.7 %.
[a] _ + 18.2 ' (0.50 in methanol) EXAMPLE XXVII
(S)-2-(2,4-Dichlorophenyl)-1,3-propanediol monocarbamate The title compound was synthesized in a similar manner to that of Example XXII, except that (S)-3-acetoxy-2-(2,4-dichlorophenyl)propanol carbamate, instead of (S)-3-acetoxy-2-phenylpropanol carbamate, was used as a starting material. Yield 78.9 %. Purity 99.7 %.
W096109283 " - PCTlKR95100124 [a] _ + 18.0 ' (0.50 in methanol) EXAMPLE XXVIII
(S)-2-(2,4-dimethoxyphenyl)-1,3-propanediol monocarbamate The title compound was synthesized in a similar manner to that of Example XXII, except that (S)-3-acetoxy-2-(2,4-dimethoxyphenyl)propanol carbamate, instead of (S)-3-acetoxy-2-phenylpropanol carbamate, was used as a starting material. Yield 65.3 ~. Purity 99.2 ~.
[a] _ + 25.1 ' (0.50 in methanol) Other features, advantages and embodiments of the present invention disclosed herein will be readily apparent to those exercising ordinary skill after reading the foregoing disclosures. In this regard, while specific embodiments of the invention have been described in considerable detail, variations and modifications of these embodiments can be effected without departing from the spirit and scope of the invention as described and claimed.
Claims (12)
1. (S)-2-Aryl-1,3-propanediol monocarbamate, represented by the following Formula I:
wherein, R is wherein X is an oxygen atom or a sulfur atom; and Y
represents a halogen element, trifluoromethyl, or a lower alkyl group containing one to three carbon atoms.
wherein, R is wherein X is an oxygen atom or a sulfur atom; and Y
represents a halogen element, trifluoromethyl, or a lower alkyl group containing one to three carbon atoms.
2. (S)-3-Acetoxy-2-arylpropanol carbamate, represented by the following Formula II:
wherein, R is wherein X is an oxygen atom or a sulfur atom; and Y
represents a halogen element, trifluoromethyl, or a lower alkyl group containing one to three carbon atoms.
wherein, R is wherein X is an oxygen atom or a sulfur atom; and Y
represents a halogen element, trifluoromethyl, or a lower alkyl group containing one to three carbon atoms.
3. A process for preparing (S)-3-acetoxy-2-arylpropanol carbamate, represented by the following Formula II:
wherein, R is wherein X is an oxygen atom or a sulfur atom; and Y
represents a halogen element, trifluoromethyl, or a lower alkyl group containing one to three carbon atoms, in which (R)-3-acetoxy-2-aryl-propanol, represented by the following Formula III:
wherein R is as defined above, is reacted with phosgene in the presence of amine base in a solvent mixture of aromatic hydrocarbon and halogenohydrocarbon and then with ammonia, whereby a high optical purity can be obtained.
wherein, R is wherein X is an oxygen atom or a sulfur atom; and Y
represents a halogen element, trifluoromethyl, or a lower alkyl group containing one to three carbon atoms, in which (R)-3-acetoxy-2-aryl-propanol, represented by the following Formula III:
wherein R is as defined above, is reacted with phosgene in the presence of amine base in a solvent mixture of aromatic hydrocarbon and halogenohydrocarbon and then with ammonia, whereby a high optical purity can be obtained.
4. The process in accordance with claim 3, wherein said solvent mixture comprises an aromatic hydrocarbon selected from the group consisting of benzene, toluene and xylene and a halogenohydrocarbon selected from the group consisting of chloroform, dichloromethane, 1,2-dichloroethane, and trichloroethane.
5. The process in accordance with claim 4, wherein said solvent mixture comprises toluene and dichloromethane.
6. The process in accordance with claim 3, wherein said amine base is selected from the group consisting of antipyrine, diisopropylethyl amine, diethyl amine, triethyl amine and pyridine.
7. The process in accordance with claim 3, wherein reaction temperature is -30 to 0 °C for phosgen and -70 °C to 0 °C for ammonia.
8. The process in accordance with claim 3, wherein said ammonia condensed to liquid and is used in an excess of 10 to 100 equivalents.
9. A process for preparing (S)-2-aryl-1,3-propanediol monocarbamate, represented by the following Formula I:
wherein, R is wherein X is an oxygen atom or a sulfur atom; and Y
represents a halogen element, trifluoromethyl, or a lower alkyl group containing one to three carbon atoms, in which (S)-3-acetoxy-2-aryl-propanol carbamate, represented by the following Formula II:
wherein R is as defined above, is dissolved in a phosphate buffer solution and added with a hydrolase selected from the group consisting of a lipase extracted from pig's pancreas, Candida lipase, Aspergillus lipase, Pseudomonas lipase and an esterase extracted from pig's liver with vigorous stirring, whereby a high optical purity can be obtained.
wherein, R is wherein X is an oxygen atom or a sulfur atom; and Y
represents a halogen element, trifluoromethyl, or a lower alkyl group containing one to three carbon atoms, in which (S)-3-acetoxy-2-aryl-propanol carbamate, represented by the following Formula II:
wherein R is as defined above, is dissolved in a phosphate buffer solution and added with a hydrolase selected from the group consisting of a lipase extracted from pig's pancreas, Candida lipase, Aspergillus lipase, Pseudomonas lipase and an esterase extracted from pig's liver with vigorous stirring, whereby a high optical purity can be obtained.
10. The process in accordance with claim 9, wherein the reaction is carried out at a temperature of 0 to 35°C
under ordinary pressure.
under ordinary pressure.
11. The process in accordance with claim 9, wherein said phosphate buffer solution has a pH of 6 to 9 and a concentration of 0.01 to 0.1 M.
12. The process in accordance with claim 9, wherein said hydrolase is an esterase extracted from pig's liver.
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1019940023910A KR0150239B1 (en) | 1994-09-22 | 1994-09-22 | Novel 2-phenyl-1,3-propanediol monocarbamate compounds |
| KR1994/23912 | 1994-09-22 | ||
| KR1019940023912A KR0139717B1 (en) | 1994-09-22 | 1994-09-22 | Carbamic compound |
| KR1019940023911A KR0141286B1 (en) | 1994-09-22 | 1994-09-22 | Carbametic compositions |
| KR1994/23911 | 1994-09-22 | ||
| KR1994/23910 | 1994-09-22 | ||
| PCT/KR1995/000124 WO1996009283A1 (en) | 1994-09-22 | 1995-09-21 | Novel carbamate compounds and processes for preparing the same |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CA2176960A1 CA2176960A1 (en) | 1996-03-28 |
| CA2176960C true CA2176960C (en) | 2007-05-01 |
Family
ID=38051327
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002176960A Expired - Fee Related CA2176960C (en) | 1994-09-22 | 1995-09-21 | Novel carbamate compounds and processes for preparing the same |
Country Status (1)
| Country | Link |
|---|---|
| CA (1) | CA2176960C (en) |
-
1995
- 1995-09-21 CA CA002176960A patent/CA2176960C/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CA2176960A1 (en) | 1996-03-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US6127412A (en) | Halogen substituted carbamate compounds from 2-phenyl-1,2-ethanediol | |
| EP1877365B1 (en) | Acetylene derivatives | |
| EP1701946A2 (en) | Derivatives of 1-piperazine- and 1-homopiperazine-carboxylates, preparation method thereof and use of same as inhibitors of the faah enzyme | |
| WO2004020430A2 (en) | Derivatives of dioxane-2-alkyl carbamates, preparation method thereof and application of same in therapeutics | |
| EP1673337B1 (en) | Arylalkylcarbamate derivatives, preparation method thereof and use of same in therapeutics | |
| US20010034365A1 (en) | Halogen substituted carbamate compounds from 2-phenyl-1,2-ethanediol | |
| JPWO2002070512A1 (en) | Method for producing 2-azetidinone derivative | |
| CA2176960C (en) | Novel carbamate compounds and processes for preparing the same | |
| EP0730575B1 (en) | Novel carbamate compounds and processes for preparing the same | |
| EP0802901B1 (en) | Novel carbamate compounds containing thiocarbamoyl group and process for preparing the same | |
| EP0842148A1 (en) | Benzenesulphonamide derivatives, preparation thereof and therapeutical uses thereof | |
| US5939554A (en) | Diarylaminopropanediol and diarylmethyl-oxazolidinone compounds | |
| US5654461A (en) | Sulfamate compound containing carbamoyl group | |
| KR0139717B1 (en) | Carbamic compound | |
| KR0141286B1 (en) | Carbametic compositions | |
| US20060074238A1 (en) | Asymmetric process for the preparation of diarylethylpiperazines derivatives and novel asymmetric diarylmethylamines as intermediates | |
| CA2267247C (en) | Heteroaryloxyethylamines as 5-ht1a ligands | |
| JPH0823997A (en) | Production of optically active 1,2-diol | |
| JPH06205686A (en) | Production of optically active 1,4-dihydropyridine compound having selective steric configuration | |
| JPH05284986A (en) | Production of optically active 1,4-dihydropyridine compound | |
| JPH06181797A (en) | Production of 1,4-dihydropyridine derivative | |
| JPH0755157B2 (en) | Production method of optically active alcohol and ester by biochemical method |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request | ||
| MKLA | Lapsed |